There is no known upper limit on how many times you can catch COVID-19. People have documented three, four, and even five or more infections since the pandemic began, and the combination of waning immunity and constantly evolving viral variants means reinfections will keep happening for the foreseeable future. What changes with each round, though, is a complex mix of severity, immune memory, and cumulative health risk that makes the picture far less simple than “you’ve had it, you’re done.”
Why Reinfections Keep Happening
Two forces work together to make repeat COVID infections possible. The first is that your immune defenses against SARS-CoV-2 fade over time. After a natural infection, antibodies targeting the virus follow a predictable decline. One longitudinal study tracked antibody levels for over a year and found that antibodies against the spike protein’s receptor-binding domain had a half-life of about 725 days, while antibodies against another viral protein (nucleocapsid) dropped faster, with a half-life of roughly 283 days.1PubMed Central. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection A separate study found that neutralizing antibody levels in people who had mild illness were remarkably stable, with a half-life estimated at nearly six years, while those who had been hospitalized saw a faster initial drop followed by stabilization.2Med. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes The takeaway is that antibodies stick around longer than early pandemic fears suggested, but they do fade, and their ability to block infection weakens well before they disappear entirely.
The second force is the virus itself. SARS-CoV-2 mutates rapidly, and each new variant carries changes that help it slip past antibodies trained on earlier versions. The Omicron lineage was a turning point: it carried roughly 60 mutations across its genome, with a heavy concentration in the spike protein’s receptor-binding domain, the exact region your antibodies target most aggressively.3PubMed Central. Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants These changes both increased how tightly the virus latches onto human cells and allowed it to dodge existing immune defenses. Every subsequent Omicron subvariant has continued this trend, which is why even people with recent infections or up-to-date vaccinations can still get infected.
How Long Between Infections
Early in the pandemic, reinfection was considered rare and typically happened many months after a first bout. A study of healthcare workers tracked over two years of the pandemic found the average interval between infections was about 14 months, stretching to roughly 16 months during the Omicron wave.4Scientific Reports. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic But as more immune-evasive variants emerged, reinfection windows shortened. By 2022 and 2023, intervals of three to six months between infections were no longer unusual. The vast majority of reinfections in that healthcare worker cohort, about 88 percent, occurred during the Omicron period, underscoring how much variant evolution compressed the timeline.
Your personal window depends on several factors: how recently you were infected or vaccinated, which variant you caught, and how robust your immune response was. A mild infection that barely triggered an immune response might leave you vulnerable sooner than a more significant one. There is no fixed “safe” period after which reinfection becomes likely, but the general trend is clear: protection against catching the virus again erodes within months, even if protection against severe illness lasts longer.
What Keeps Severe Disease at Bay
Here is the more reassuring side of the story: even when antibodies can no longer block infection outright, a deeper layer of immune memory usually prevents the worst outcomes. T cells, a branch of the immune system that targets and destroys infected cells, appear to be the main reason most reinfections are milder than first infections. Research shows that T cell memory plays a key role in preventing severe disease and limiting reinfection, in part because T cells can recognize parts of the virus that are more stable across variants.5PubMed Central. T cell immune memory after covid-19 and vaccination A study examining T cell responses in the post-pandemic period confirmed that this memory is durable, broadly targeted, and able to cross-react even with heavily mutated variants.6Cell Host & Microbe. Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
The real-world data backs this up. A large study comparing first infections with reinfections found that people experiencing their second bout had significantly lower rates of hospitalization, need for critical care, and mechanical ventilation.7Journal of Infection and Public Health. Real-world assessment of reinfection with SARS-CoV-2: Implications for vaccines The same study found reduced risks of downstream complications across the circulatory and respiratory systems, including lower rates of pneumonia, blood clots, and heart-related problems. Another observational study reported that first infections carried about double the risk of severe clinical outcomes compared with second infections.8PubMed Central. Demographic and socioeconomic characteristics associated with SARS-CoV-2 reinfection: An observational study So while you can get reinfected, your body generally handles it better each time, at least in terms of acute illness.
The Cumulative Risk Problem
The finding that individual reinfections tend to be milder is real, but it does not tell the whole story. There is growing evidence that each additional infection adds to the total burden on your body, even if any single episode feels manageable. A study highlighted by New Scientist found that people who caught the virus two or three times went on to have higher rates of heart disease, kidney problems, and other complications compared with people who had been infected only once.9PubMed Central. The risks from covid-19 reinfection The concern is that each infection causes a degree of organ stress or inflammatory damage that accumulates over time, even when you feel fine during the acute phase.
Long COVID risk also appears to increase with repeated infections. A study of healthcare workers found that the overall cumulative risk of long COVID among those infected was about 17 percent, and that risk climbed with each additional infection.10PubMed. Long COVID risk and severity after COVID-19 infections and reinfections In children and adolescents, reinfection was associated with roughly double the risk of a post-acute sequelae diagnosis compared with a single infection, along with elevated rates of conditions ranging from fatigue and cognitive impairment to myocarditis and blood clots.11The Lancet Infectious Diseases. Post-acute sequelae of SARS-CoV-2 reinfection in children and adolescents This is perhaps the most important reason to avoid getting reinfected when reasonably possible: even if each round feels like a cold, the long-term accumulation of risk is harder to see and harder to reverse.
Hybrid Immunity and the Vaccine Factor
The strongest protection researchers have identified comes from what they call hybrid immunity: the combination of vaccination and at least one natural infection. A study of healthcare workers during the Omicron wave found that those with hybrid immunity had a reinfection rate of about 10 percent, compared with roughly 44 to 46 percent among those who had only vaccination-induced immunity, including those with booster doses. That translates to about five-fold higher protection from hybrid immunity.12PubMed Central. Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers Other research confirmed that hybrid immunity also provides more durable cross-variant protection, including among people with compromised immune systems.13Journal of Infection. Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals
Vaccines on their own still offer meaningful protection, though it fades. A European meta-analysis of studies through early 2024 found that the primary vaccine series was about 71 percent effective against infection in the first months, but dropped to about 39 percent after six months. Booster doses pushed effectiveness back up to about 76 percent, though that too declined to around 58 percent after three months.14European Respiratory Review. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults The practical implication: staying current with boosters lowers your chance of infection, and the combination of vaccination plus prior infection gives you the strongest shield available.
The Immune Imprinting Wrinkle
There is a catch to all of this immune layering, and it is one of the more actively debated topics in COVID immunology. When your immune system encounters a new variant after being trained by an older one, whether through vaccination or prior infection, it tends to dust off antibodies made for the original version rather than building new ones tailored to the variant in front of it. Researchers call this immune imprinting, and it can leave blind spots. A study of people who had received three vaccine doses and then experienced an Omicron breakthrough infection found that their antibody response was largely a recall of memory generated by the original vaccine, rather than a fresh response to Omicron’s unique features. Antibody and memory B cell responses targeting the regions where Omicron differed from earlier strains were impaired.15PubMed Central. Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
This phenomenon, sometimes referred to as “original antigenic sin,” raises the concern that repeated exposures to slightly different versions of the virus could progressively narrow the immune system’s flexibility, making it harder to respond to future variants that diverge even more from the ancestral strain.16PubMed Central. Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants Updated vaccine formulations are partly designed to counteract this effect, but the degree to which imprinting limits real-world protection remains an open and actively studied question. T cells appear less susceptible to this problem because they target more conserved parts of the virus, which is one reason they remain such an important backstop.
The Mucosal Immunity Gap
One reason reinfections are so common, even among people with strong blood-level immunity, is that the virus enters through the nose and throat, and most of the immune defense that matters there is local. Current vaccines, which are all injected into muscle, are excellent at generating antibodies in the bloodstream and training T cells, but they are less effective at building immunity right at the mucosal surfaces where SARS-CoV-2 first takes hold. Mucosal immunity, including secretory IgA antibodies in the respiratory tract, plays a key role in the early restriction of viral replication and clearance of the virus.17PubMed Central. Mucosal immunity in COVID-19: a comprehensive review This local defense may explain why many infections are mild or asymptomatic in people with prior exposure: the virus gets in, but mucosal defenses limit how far it spreads before systemic immunity kicks in. Nasal and inhaled vaccines currently in development aim to strengthen this mucosal layer directly, which could, in theory, reduce reinfection rates more effectively than intramuscular shots alone.
Children and Reinfection
Kids get reinfected, but early data suggested they were reinfected less often than adults. A national surveillance study in England covering the first year and a half of the pandemic found that the reinfection rate in children was about 0.34 percent overall, with the youngest children (under five) having the lowest rate at 0.18 percent. Adults, by comparison, had a reinfection rate of 0.73 percent.18The Lancet Child & Adolescent Health. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England Among the children who were hospitalized with reinfection, about 72 percent had underlying health conditions. Reassuringly, hospitalization rates were similar for first and second episodes, intensive care admissions were rare, and no children in the study died after a reinfection.
Those figures come from the pre-Omicron era, however, and rates have shifted since. And the long COVID data from children mentioned earlier is worth repeating here in context: reinfection roughly doubled the risk of post-acute sequelae in children and adolescents, which is a reminder that “mild acute illness” and “no long-term consequences” are not the same thing.
Who Faces the Highest Reinfection Risk
People with weakened immune systems face a distinctly different reality. Immunocompromised individuals, including those on certain cancer treatments, organ transplant recipients, and people with autoimmune conditions requiring immunosuppressive drugs, often mount weaker immune responses to both infection and vaccination. This leaves them vulnerable not just to reinfection but to a condition called persistent COVID, where the virus continues to replicate actively for weeks or months rather than being cleared.19Clinical Microbiology and Infection. Management of persistent COVID-19 in immunocompromised patients In one study of immunocompromised patients with prolonged or relapsed viral shedding, about 35 percent showed evidence of reinfection with a different variant, rather than simply continuing to shed virus from a single infection.20PubMed Central. Reinfection of SARS-CoV-2 Variants in Immunocompromised Patients with Prolonged or Relapsed Viral Shedding
Distinguishing true reinfection from prolonged shedding is a clinical challenge in this population. A patient who keeps testing positive weeks after their initial diagnosis might be harboring lingering virus from the original infection or might have caught a new variant. Cycle threshold values on PCR tests can help differentiate between the two scenarios, but the distinction is not always clear-cut.21PubMed Central. Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient For immunocompromised individuals, the practical message is that hybrid immunity still helps, but the protection it provides is less reliable and shorter-lived than in people with normal immune function.
When Reinfection Looks Like Something Else
Not all reinfections announce themselves with obvious symptoms. One study found that about 13 percent of first COVID infections were completely asymptomatic.22PubMed Central. COVID-19 primary infection, reinfection, and its associated clinical presentations Reinfections, especially in people with substantial prior immunity, are even more likely to fly under the radar. You might attribute a day of fatigue and a scratchy throat to allergies, never test, and never know you were reinfected. This makes accurate reinfection counting nearly impossible at the population level. The true number of times any given person has been infected is almost certainly higher than their official count.
Home rapid tests add another layer of ambiguity. They are less sensitive than PCR tests, especially early in an infection or when viral loads are low. Someone who tests negative on a rapid test but has symptoms might be in the early window of a reinfection. The decline in widespread PCR testing infrastructure since 2022 means that confirmed reinfection data increasingly underestimates reality.
How COVID Compares to Other Coronaviruses
Reinfection is not unique to SARS-CoV-2. The four seasonal coronaviruses that cause a share of common colds have been reinfecting people for decades, and researchers have looked to them for clues about where SARS-CoV-2 is heading.23PubMed Central. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households With seasonal coronaviruses, reinfection with the same virus can occur within a year, and people get infected by the same four viruses repeatedly across their lifetimes without building permanent immunity.24PubMed Central. SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses The key difference is that those seasonal coronaviruses cause relatively mild illness in most people, whereas SARS-CoV-2 carries a heavier burden of severe disease, organ damage, and post-acute complications. As population immunity deepens through repeated exposure and vaccination, the hope is that SARS-CoV-2 will follow a trajectory toward something more like a seasonal coronavirus in terms of severity, but the timeline and completeness of that transition remain genuinely uncertain.
Behavioral Shifts After Vaccination
An underappreciated factor in reinfection rates is behavior. Early in the vaccine rollout, there was concern that vaccinated people would abandon precautions like masking and distancing, a concept known as risk compensation. If people dramatically increased their exposure after getting vaccinated, the real-world benefit of the vaccine could shrink. Modeling work suggested this was a legitimate theoretical concern.25PubMed Central. Benefit of COVID-19 vaccination accounting for potential risk compensation However, a study using real-world data from South Korea, tracking credit card spending, airline travel, and survey responses, found no evidence that people actually changed their behavior in measurable ways immediately after becoming eligible for vaccination.26PubMed. Risk compensation after COVID-19 vaccination: Evidence from vaccine rollout by exact birth date in South Korea Of course, the broader relaxation of pandemic precautions over time, driven by policy changes, fatigue, and evolving norms rather than individual vaccination decisions, has clearly increased everyone’s exposure. The virus is simply harder to avoid now than it was when people were actively trying to avoid it, which contributes to cumulative reinfection counts independently of any immune considerations.